Kern Pharma already has alternative plan for the return

After the initial stick by Not being among the guests on the return 2025, of rapping the wounds, Juanjo Oroz Kern Pharma has no choice but to rebuild and continue. The green set staff has designed An alternative calendar with stages and classic laps, races around the world that are going to pivot on a beginning: get points to enter among the top 30 of the ICU at the end of the season.

“It is clear that if you have less calendar there are fewer opportunities to score and be among the 30 best,” explains Oroz. “The calendar is wide, but we are not going to go crazy. We want to give balance and coherence, We are going to first quality, taking into account that we are still Less important races, but with our best runners in search of results. ”

Kern Pharma has had to rethink his calendar, and in parallel the preparation of his runners. Those who started the season have just left a small break, to relaunch their plan progressively.

Thus the team leader, Urko Berrion, He will go to Hungary and Slovenia, with the idea of ​​disputing them. The also Navarro Diego Uriartethe other winner of the team so far this year, will return to the Mercant Tour, Slovenia and the Championships of Spain of Crono.

Core Phama He has divided his template into two blocks. Brustenga, Pau Miquel, Galván and Haimar Etxeberria They will be the struts to get the maximum number of possible points in one day races. From here at the end of the year 4 in Spain, 4 in Italy and at least another four between France and Belgium. Tests that offer very good option but to fight for victory, if you add many points. The other part of the team would focus on stages.

“We are going to focus more on getting points than what we have done so far, because we have to give viability to this structure, and for that we have to be among the 30 ”, Oroz says. “The mentality that we are going to run is that for us, in terms of points, any race is equally important than the return, you don’t have to do less to any career.”

Kern Pharma aspires to become the first pro team that does not run in the big ones. A great challenge for the remainder of the year.